# China NMPA Drug Inspection - Anguo Lulutong Traditional Chinese Medicine Pieces Co., Ltd.

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/anguo-lulutong-traditional-chinese-medicine-pieces-co-ltd/6ce426d2-3188-41cb-ab0f-97be5ff1d510/
Source feed: China

> China NMPA drug inspection for Anguo Lulutong Traditional Chinese Medicine Pieces Co., Ltd. published November 18, 2019. Drug: . The Shandong Provincial Food and Drug Administration announced findings from quality inspections in Issue No. 7, 2018 (p

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Announcement from Shandong Provincial Food and Drug Administration Regarding 13 Batches of Drugs Failing Quality Inspection (Issue No. 7, 2018)
- Company Name: Anguo Lulutong Traditional Chinese Medicine Pieces Co., Ltd.
- Publication Date: 2019-11-18
- Inspection Finding: The quality does not meet the standard requirements.
- Action Taken: The relevant municipal food and drug administration bureaus have taken control measures such as sealing, seizing, suspending sales, and recalling the substandard products, and have filed cases against the relevant manufacturers and sampled units in accordance with relevant laws and regulations.
- Summary: The Shandong Provincial Food and Drug Administration announced findings from quality inspections in Issue No. 7, 2018 (published July 4, 2018), revealing that 13 batches of drugs failed quality standards. Inspections by seven drug testing institutions, including the Taian Municipal Food and Drug Inspection and Testing Center, identified substandard products from various manufacturers. These included two batches of finished drugs from companies such as Shanghai Pukang Pharmaceutical Co., Ltd., and eleven batches of traditional Chinese medicine decoction pieces from companies like Anguo Putianhe Traditional Chinese Medicine Pieces Co., Ltd. Operating under the provincial regulatory framework, municipal food and drug administrations initiated immediate control measures. These actions included sealing and seizing the affected products, suspending sales, and issuing recalls. Furthermore, legal cases have been filed against the non-compliant manufacturers and sampled units. Companies are required to investigate the root causes of these quality deficiencies, develop and implement comprehensive rectification plans, and effectively eliminate potential risks to ensure public safety and product integrity.

Company: https://www.globalkeysolutions.net/companies/anguo-lulutong-traditional-chinese-medicine-pieces-co-ltd/14e9df8b-b3b0-44dd-ae39-a5c87a2dc03e/